glp 1 investing Weight loss drugs and stocks: Breaking down the GLP1 market for investors GLP-1 Lasting Outcomes
Description
Now, where we're at today is that we do have some encouraging signals in both imaging and some small trials
In addition, there was a lower incidence of nephropathy and a non-significantly higher incidence of retinopathy ( p = 0.33) in the liraglutide group in LEADER
plantarum TENSIA and L
10.1136/bjophthalmol-2016-308894
Injections win for consistent dosing and trial-backed schedules
Pricing ranges from $265 to $649/month depending on the treatment protocol consultation fees and lab work are extra
